RBC Life Sciences, Inc.
RBC Life Sciences, Inc.
Aktie · US74926T2015 (OTC)
Übersicht
Kein Kurs
Schlusskurs OTC 08.12.2025: 0,0002 USD
08.12.2025 21:00
Aktuelle Kurse von RBC Life Sciences, Inc.
BörseTickerWährungLetzter UmsatzKursTagesveränderung
OTC: UTC
UTC
RBCL
USD
08.12.2025 21:00
0,0002 USD
0,00 USD
Firmenprofil zu RBC Life Sciences, Inc. Aktie
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.
Erhalte tagesaktuelle Insights vom finAgent über RBC Life Sciences, Inc.

Unternehmensdaten

Name RBC Life Sciences, Inc.
Firma RBC Life Sciences, Inc.
Website https://www.rbclifesciences.com
Heimatbörse OTC UTC
ISIN US74926T2015
Wertpapierart Aktie
Sektor Consumer Defensive
Branche Household & Personal Products
CEO David Price
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 2301 Crown Court, 75038 Irving
IPO Datum 2000-01-03

Ticker Symbole

Name Symbol
Over The Counter RBCL
Weitere Aktien
Investoren, die RBC Life Sciences, Inc. halten, haben auch folgende Aktien im Depot:
GENL MILLS 25/32
GENL MILLS 25/32 Anleihe
m-up holdings, Inc.
m-up holdings, Inc. Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025